Siegfried To Create Functional Organization
Published: 02-Feb-2010
Siegfried Group will be introducing a functional organization to replace its current two-division structure, effective March 1, 2010. The new structure is a result of strategic adjustments approved in the summer of 2009. Siegfried will increasingly market its two core capabilities, namely the development and production of active pharmaceutical ingredients and finished dosage forms, as a single package.
Rudolf Hanko, CEO of Siegfried, said: “Siegfried is one of the rare suppliers of the pharmaceutical industry that is capable of providing both the chemical synthesis of active pharmaceutical ingredients and production of finished dosage forms. Our new organizational structure will make allowance for this fact. In the future we will be able to convey this attractive offer in a much more effective way.”
Reportedly, the future executive committee of Siegfried will consist of seven members. Rudolf Hanko, CEO, Michael Husler, CFO, and Hanspeter Brun, head of HR, will continue in the same function.
Marianne Spane, formerly head of Siegfried Generics division, will be responsible for business development and sales. Hubert Stuckler, formerly head of the Siegfried actives division, will be responsible for the world-wide technical operations. Former chief communications officer, Peter Gehler, will head the Corporate Center, which includes communication, the legal department, facility management and the chairman’s office.
In addition to his duties as CEO, Rudolf Hanko will assume responsibility for research & development on an interim basis until the position of head of R&D is filled.
Network Sites

Suppliers To This Sector
Browse A-Z
ADAPT Localization
The Translation and Localization Specialists ...
Almac
Drug Development Solutions ...
Cerbios-Pharma SA
High Quality & Reliable Services ...
CurTec
Producer & Manufacturer of Plastics Packaging ...
Lonza Custom Manufacturing
Bioresearch Products, Development Services and Manufacturing for Functional and Active Ingredients ...
Medilingua Translations
The Medical Translation Specialists ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully